Ligand validation:5Y8N

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 5Y8N designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5Y8N_NAD_B_301	74%	42%	0.132	0.962	0.87	1.35	1	7	0	0	100%	1
5Y8N_NAD_A_301	60%	42%	0.155	0.94	0.92	1.31	2	5	0	0	100%	0.8
5Y8L_NAD_B_301	99%	40%	0.052	0.984	1.05	1.27	5	9	0	0	100%	1
5Y8M_NAD_B_301	89%	32%	0.088	0.968	1.16	1.51	6	10	0	0	100%	1
5Y8H_NAD_B_301	88%	31%	0.085	0.962	1.06	1.68	1	9	0	0	100%	0.8
5Y8O_NAD_B_301	18%	32%	0.228	0.817	1.17	1.53	4	10	0	0	100%	0.7
3CMC_NAD_R_408	100%	20%	0.016	0.998	1.63	1.74	4	9	0	0	100%	1
4RQU_NAD_B_403	100%	3%	0.019	0.997	3.51	2.61	13	18	0	0	100%	1
3EC7_NAD_A_400	100%	18%	0.025	0.995	1.8	1.74	5	8	1	0	100%	1
4URF_NAD_A_1249	100%	44%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	23%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.